Literature DB >> 8623923

Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region.

L Flenghi1, B Bigerna, M Fizzotti, S Venturi, L Pasqualucci, S Pileri, B H Ye, M Gambacorta, R Pacini, C D Baroni, E Pescarmona, I Anagnostopoulos, H Stein, G Asdrubali, M F Martelli, P G Pelicci, R Dalla-Favera, B Falini.   

Abstract

The human BCL-6 gene, which is rearranged in approximately 30% of diffuse large B cell lymphomas, encodes a 706-amino-acid nuclear protein of the Kruppel-type zinc finger transcription factors mainly expressed in normal germinal center B cells and related lymphomas. Four monoclonal antibodies (PG-B6, PG-B6a, PG-B6p, and PG-B6m), specifically directed against the human BCL-6 protein, were generated by immunizing BALB/c mice with a recombinant protein corresponding to the BCL-6 amino-terminal region (amino acids 3 to 484). The PG-B6 monoclonal antibody reacted with a BCL-6 epitope sensitive to fixatives and preserved in all mammalian species. PG-B6a (a is for avian) recognized the most evolutionarily conserved BCL-6 epitope (expressed in all animal species including avian). PG-B6p (p is for paraffin) recognized a fixative-resistant epitope of BCL-6 that was detectable on paraffin sections after microwave heating in 1 mmol/L EDTA buffer. PG-B6m (m is for mantle) was the least specific monoclonal antibody as, in addition to BCL-6, it reacted with a yet undefined antigen selectively located in the cytoplasm of mantle and marginal zone B cells. All monoclonal antibodies detected strong nuclear expression of BCL-6 in follicular lymphomas, diffuse large B cell lymphomas, Burkitt's lymphomas, and nodular, lymphocyte-predominance Hodgkin's disease. In diffuse large B cell lymphomas, BCL-6 expression was independent of BCL-6 gene rearrangements and did not correlate with expression of other markers or the proliferation index. BCL-6 was not expressed in B-CLL, hairy cell leukemia, mantle-cell- and marginal-zone-derived lymphomas. Labeling of paraffin sections with PG-B6p proved useful for differentiating proliferation centers in B-CLL (BCl-2+/BCL-6-) from trapped germinal centers in mantle cell lymphomas (BCL-2-/BCL-6+) and for identifying neoplastic cells in cases of nodular, lymphocyte-predominance Hodgkin's disease. Because of their high specificity, wide reactivity in humans and animal species including avians (PG-B6a), and suitability for labeling routine paraffin sections (PG-B6p), the reagents described in this paper should prove valuable in both research and diagnostics.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8623923      PMCID: PMC1861546     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.

Authors:  W Timens; L Visser; S Poppema
Journal:  Lab Invest       Date:  1986-04       Impact factor: 5.662

2.  Immunohistochemical demonstration of follicular dendritic cells in bone marrow involvement of B-cell chronic lymphocytic leukemia.

Authors:  M Chilosi; G Pizzolo; F Caligaris-Cappio; A Ambrosetti; F Vinante; L Morittu; F Bonetti; L Fiore-Donati; G Janossy
Journal:  Cancer       Date:  1985-07-15       Impact factor: 6.860

3.  Updated Kiel classification for lymphomas.

Authors:  A G Stansfeld; J Diebold; H Noel; Y Kapanci; F Rilke; G Kelényi; C Sundstrom; K Lennert; J A van Unnik; O Mioduszewska
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

4.  The GLI-Kruppel family of human genes.

Authors:  J M Ruppert; K W Kinzler; A J Wong; S H Bigner; F T Kao; M L Law; H N Seuanez; S J O'Brien; B Vogelstein
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

5.  A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells.

Authors:  L Flenghi; B H Ye; M Fizzotti; B Bigerna; G Cattoretti; S Venturi; R Pacini; S Pileri; F Lo Coco; E Pescarmona
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

6.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

Review 7.  The normal and malignant germinal centre.

Authors:  H Stein; J Gerdes; D Y Mason
Journal:  Clin Haematol       Date:  1982-10

8.  T-cell-rich B-cell lymphoma.

Authors:  A D Ramsay; W J Smith; P G Isaacson
Journal:  Am J Surg Pathol       Date:  1988-06       Impact factor: 6.394

9.  Inhibition of endogenous tissue alkaline phosphatase with the use of alkaline phosphatase conjugates in immunohistochemistry.

Authors:  B A Ponder; M M Wilkinson
Journal:  J Histochem Cytochem       Date:  1981-08       Impact factor: 2.479

10.  Immunoarchitecture of the "pseudofollicles" of well-differentiated (small) lymphocytic lymphoma: a comparison with true follicles.

Authors:  H Ratech; K Sheibani; B N Nathwani; H Rappaport
Journal:  Hum Pathol       Date:  1988-01       Impact factor: 3.466

View more
  13 in total

1.  Primary diffuse large B-cell lymphoma of the oral cavity: germinal center classification.

Authors:  Indraneel Bhattacharyya; Hardeep K Chehal; Donald M Cohen; Samer Z Al-Quran
Journal:  Head Neck Pathol       Date:  2010-06-09

2.  ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum.

Authors:  B Falini; B Bigerna; M Fizzotti; K Pulford; S A Pileri; G Delsol; A Carbone; M Paulli; U Magrini; F Menestrina; R Giardini; S Pilotti; A Mezzelani; B Ugolini; M Billi; A Pucciarini; R Pacini; P G Pelicci; L Flenghi
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

3.  Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein.

Authors:  Roberta Carbone; Oronza A Botrugno; Simona Ronzoni; Alessandra Insinga; Luciano Di Croce; Pier Giuseppe Pelicci; Saverio Minucci
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

4.  Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms.

Authors:  Teresa Marafioti; Stefano Ascani; Karen Pulford; Elena Sabattini; Milena Piccioli; Margaret Jones; Pier Luigi Zinzani; Georges Delsol; David Y Mason; Stefano A Pileri
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

5.  T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6.

Authors:  A L Dent; J Hu-Li; W E Paul; L M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

6.  Analysis of chromosomal copy number changes and oncoprotein expression in primary central nervous system lymphomas: frequent loss of chromosome arm 6q.

Authors:  Ronald Boonstra; Alice Koning; Mirjam Mastik; Anke van den Berg; Sibrand Poppema
Journal:  Virchows Arch       Date:  2003-06-12       Impact factor: 4.064

7.  Initial clonal expansion of germinal center B cells takes place at the perimeter of follicles.

Authors:  Francis Coffey; Boris Alabyev; Tim Manser
Journal:  Immunity       Date:  2009-03-19       Impact factor: 31.745

8.  Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins.

Authors:  Stefano A Pileri; Gianluca Gaidano; Pier Luigi Zinzani; Brunangelo Falini; Philippe Gaulard; Emanuele Zucca; Federica Pieri; Eva Berra; Elena Sabattini; Stefano Ascani; Milena Piccioli; Peter W M Johnson; Roberto Giardini; Edoardo Pescarmona; Domenico Novero; Pier Paolo Piccaluga; Teresa Marafioti; Miguel A Alonso; Franco Cavalli
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

Review 9.  BCOR gene alterations in hematologic diseases.

Authors:  Paolo Sportoletti; Daniele Sorcini; Brunangelo Falini
Journal:  Blood       Date:  2021-12-16       Impact factor: 22.113

10.  Immunophenotype classification and therapeutic outcomes of Chinese primary gastrointestinal diffuse large B-cell lymphoma.

Authors:  Zizhen Zhang; Yanying Shen; Danping Shen; Xingzhi Ni
Journal:  BMC Gastroenterol       Date:  2012-06-25       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.